Paxlovid and Other COVID-19 Meds Will Soon Have Big Price Tags

Follow Drugslib on

By Physician’s Briefing Staff HealthDay Reporter

MONDAY, Oct. 30, 2023 -- Americans have been getting COVID-19 treatments such as Paxlovid for free, but that is about to end. The medications will enter the private market this week, the Associated Press reported.

The price for a five-day course of Paxlovid, made by Pfizer, will be $1,390. Merck has not confirmed a price for its COVID-19 treatment, Lagevrio, but told the AP that it will offer the treatment free to patients "who, without assistance, could not otherwise afford the product."

The pills will still be available at no cost until those bought earlier by the federal government run out at pharmacies, hospitals, and doctors' offices, according to U.S. Health and Human Services officials. The government paid Pfizer $5 billion for 10 million courses of Paxlovid in 2021. Once those are gone, those with private insurance may notice a copay charge, the AP reported.

People on Medicaid or Medicare or without medical insurance will not pay any out-of-pocket costs for these treatments through 2024, and Pfizer will offer copay assistance for Paxlovid through 2028.

The Department of Veterans Affairs, Department of Defense, and Indian Health Service will still have access to government stores of Paxlovid, the AP reported. The federal government will also keep 1 million treatment courses in its stockpile.

Medical suppliers can begin ordering the treatment from the drug companies starting this week.

Associated Press Article

Posted : 2023-10-31 13:55

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords